Home » Newsletters » BioWorld Science

BioWorld Science

July 17, 2015

View Archived Issues

Tunable BTK inhibitors from Principia Biopharma show promise for autoimmune diseases

Fate Therapeutics establishes collaboration on NK cell-based cancer immunotherapeutics

Enumeral Biomedical updates pipeline progress

Five Prime and Inhibrx sign GITR antibody research collaboration and license agreement

Novogen's Anisina receives FDA orphan drug designation for neuroblastoma

Radius Health's RAD-1901 synergizes with other anticancer agents in breast cancer models

European Commission approves Evotaz for HIV-1 infection in adults

Johnson & Johnson highlights progress of second quarter 2015

Retinal degeneration model devised to test retinal sheet transplants

Protagonist Therapeutics raises funds to advance pipeline of oral peptide drugs

Kallikrein-11 shows potential as a brain tumor biomarker

Immunocore conducts European life sciences' largest private financing

Achaogen receives NIAID contract to develop novel antibacterials

Avineuro reports results from phase II trial of AVN-211 as schizophrenia adjuvant therapy

Bayer presents GnRH receptor antagonists

FDA grants QIDP designation to iclaprim for hospital-acquired pneumonia

Gilead discloses Na+ channel modulators

Merck & Co patents CETP inhibitors

Esteve divulges multimodal sigma1/mu-opioid receptor ligands

Amgen reports phase II trial results for blinatumomab in Ph+ ALL

Respivert and Topivert disclose protein kinase inhibitors

Yungjin Pharmaceutical starts phase IIa trial of YPL-001 for COPD

Mesenchymal stem cell-derived exosomes can enhance wound healing

New Approaches to Neuroblastoma Therapy consortium starts phase I trial of SF-1126

FDA approves Dysport for upper limb spasticity

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...